Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Loan Extension

26 Nov 2014 07:00

RNS Number : 9969X
Fitbug Holdings PLC
26 November 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

26 November 2014

Fitbug Holdings plc ('Fitbug' or 'the Company')

Agreed extension of loans to mid-2016 strengthens balance sheet

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that it has agreed that the repayment date of all loans, totalling £6.94 million, to the Company from NW1 Investments Limited will be extended to 31 July 2016. Other terms remain unchanged including the interest rate which remains at 5%.

 

NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

Fergus Kee, Chairman of Fitbug said, "We are pleased to have reached an agreement to extend the repayment date on our existing loans with NW1 Investments. It strengthens our balance sheet at an exciting time for Fitbug as we move to scale up the business to meet growing demand for wearable technology."

 

**ENDS**

For further information visit www.KiQplan.com or www.fitbugholdings.com contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce

Hybridan LLP

0203 713 4580

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

Notes

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platforms act as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com and www.KiQplan.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRFEWEFIFLSEFF
Date   Source Headline
22nd Apr 20217:00 amRNSAnnual General Meeting Statement
7th Apr 20214:41 pmRNSSecond Price Monitoring Extn
7th Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20216:11 pmRNSPosting of Annual Report & Accounts, Notice of AGM
26th Mar 20217:00 amRNSPreliminary Results for the y/e 31 December 2020
12th Feb 202110:00 amRNSBidstack teams up with Moat by Oracle
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTrading Update and Directorate Change
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:00 amRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 202111:05 amRNSSecond Price Monitoring Extn
6th Jan 202111:00 amRNSPrice Monitoring Extension
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
23rd Dec 20205:15 pmRNSBlock Listing Six Monthly Return
21st Dec 202011:00 amRNSPrice Monitoring Extension
17th Dec 20209:05 amRNSSecond Price Monitoring Extn
17th Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSTrading Update
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20202:40 pmRNSExercise of Warrants, Issue of Equity and TVR
11th Nov 20202:51 pmRNSExercise of Warrants, Issue of Equity and TVR
29th Oct 20201:20 pmRNSExercise of Warrants and Total Voting Rights
27th Oct 20208:38 amRNSBlock Listing Six Monthly Return
2nd Oct 20204:35 pmRNSPrice Monitoring Extension
24th Sep 202011:05 amRNSSecond Price Monitoring Extn
24th Sep 202011:00 amRNSPrice Monitoring Extension
24th Sep 20209:05 amRNSSecond Price Monitoring Extn
24th Sep 20209:00 amRNSPrice Monitoring Extension
23rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20204:35 pmRNSPrice Monitoring Extension
15th Sep 202011:05 amRNSSecond Price Monitoring Extn
15th Sep 202011:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSExclusive Agreement with Ubisoft for Hyper Scape
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20204:40 pmRNSSecond Price Monitoring Extn
18th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSInterim Results
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.